Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 16/20 | 0.35 |
| ▸ | ALDH3A1 | P30838 | 2/20 | 0.33 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27658949 | 0.89 | CRHR1 (0.34) | CRHR1ALDH1A1 | |
| SCHEMBL3754251 | 0.84 | TSHR (0.31) | ALDH1A3ALDH1A1 | |
| SCHEMBL2973328 | 0.79 | CRHR1 (0.33) | CRHR1ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL2974395 | 0.79 | ALDH3A1 (0.39) | CRHR1ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL2974959 | 0.79 | ALDH3A1 (0.33) | CRHR1ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL2961723 | 0.79 | ALDH3A1 (0.39) | CRHR1ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL4014825 | 0.75 | CRHR1 (0.37) | CRHR1 | |
| SCHEMBL7150417 | 0.74 | TP53 (0.41) | CRHR1ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL11082907 | 0.73 | ESR1 (0.33) | ALDH3A1ALDH1A3ALDH1A1 | |
| SCHEMBL162717 | 0.73 | MAPT (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2627324-A2 | SUBSTITUTED BENZAMIDES AND THEIR USES | The Board of Trustees of The Leland Stanford Junior University (US) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012051117-A2 | SUBSTITUTED BENZAMIDES AND THEIR USES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-04-19 | — | — | WO | disclosed |